Latest Health News
Physicians Launch 15th Annual Rx and Illicit Drug Summit
The AMA, ASAM, and APhA opened the summit in Nashville emphasizing affordable care amid a 38% drop in overdose deaths from 109,703 in Oct 2023 to 68,408 in Oct 2025, driven by fentanyl. AMA President Bobby Mukkamala stressed physician-led care and collaboration for OUD patients.
The event featured leaders from ASAM, APhA, and NIDA director Nora Volkow.
CDC Issues Health Alert on Medetomidine in Illegal Drugs
The CDC's April 2 HAN advisory warns of medetomidine, unapproved for humans, causing sedation, bradycardia, and hypotension in the drug supply. It provides recommendations for clinicians, public health, labs, and overdose risks.
This addresses rising presence in illicit drugs.
US Measles Cases on Track to Surpass 2025 Total
2026 measles cases are projected to exceed 2025, questioning the US elimination status review delay. This raises concerns over sustained control efforts.
The Johns Hopkins analysis highlights ongoing challenges.
Novartis Expands Community Health Programs for Heart Disease and Cancer
Novartis announced scaling programs to over 30 countries by 2030, including US cities, to close gaps in heart disease and cancer care. Initiatives like Inclusive Health Accelerators and CARDIO4Cities use data and AI for earlier intervention.
Pilots showed improved blood pressure control rates.
WHO Calls for Experts on New Endometriosis Guideline
WHO seeks experts for groups developing a guideline on endometriosis, affecting 10% of reproductive-age women globally. Focus areas include diagnosis, management, pain, fertility, and equity in primary care.
Applications due April 30, 2026 to MH_EN@who.int.
Trump's DOGE Impact on Global Health Landscape
One year post-Trump and Musk's Department of Government Efficiency disrupting foreign aid, effects on public health and disease management are analyzed. WTOP examines US and worldwide implications.
This follows aid cuts affecting global efforts.
US Aid Disruptions Threaten HIV and Malaria Drugs in Africa and Asia
New disruptions to US medical aid risk supplies of HIV and malaria drugs for Africa and Asia. This echoes prior interruptions amid global health challenges.
War's impact also noted in weekly roundup.
PedalPro Device Targets Blood Clot Prevention in Hospital Patients
Carle Illinois innovators develop PedalPro, a low-cost pedal device for bedridden patients to prevent DVT by maintaining blood flow. Costing ~$500, it's suitable for low-resource settings globally.
The team advances in Global Health Innovation Competition in Taiwan April 10-12.
Strengthening Scientific Collaboration for Universal Health Coverage
A April 9 event focused on GMN collaboration to advance universal health coverage through science. Broadcast on NTA Live, it highlights global efforts.
This supports broader health access initiatives.
Progress Slows on Chronic Disease Public Health Efforts Globally
Novartis notes reversing or slowing efforts against chronic diseases in many countries, prompting expanded community programs. Millions miss treatments due to access gaps.
Emphasis on sustainable solutions for low-income areas.